Nanoscale therapeutics have promise for the administration of therapeutic small molecules and biologics to the heart following myocardial infarction. Directed delivery to the infarcted region of the heart using minimally… Click to show full abstract
Nanoscale therapeutics have promise for the administration of therapeutic small molecules and biologics to the heart following myocardial infarction. Directed delivery to the infarcted region of the heart using minimally invasive routes is critical to this promise. In this review, we will discuss the advances and design considerations for two nanoscale therapeutics engineered to target the infarcted heart, nanoparticles and adeno-associated viruses.
Keywords:
heart;
myocardial infarction;
nanoscale therapeutics;
therapeutics myocardial;
targeted nanoscale
Journal Title: Biomaterials science
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Biomaterials science
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!